Anthony E. Lang

Research interests

Publications

• The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

  Movement Disorders · 2022 · https://doi.org/10.1002/mds.29005

• Parkinson disease

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.13

• Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.26987

• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.27115

• Technology in Parkinson's disease: Challenges and opportunities

  Movement Disorders · 2016 · https://doi.org/10.1002/mds.26642

• Gastrointestinal dysfunction in Parkinson's disease

  The Lancet Neurology · 2015 · 10.1016/s1474-4422(15)00007-1

• MDS clinical diagnostic criteria for Parkinson's disease

  Movement Disorders · 2015 · https://doi.org/10.1002/mds.26424

• Parkinson's disease

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(14)61393-3

• MDS research criteria for prodromal Parkinson's disease

  Movement Disorders · 2015 · 10.1002/mds.26431

• Pharmacological Treatment of Parkinson Disease

  JAMA · 2014 · 10.1001/jama.2014.3654

• Criteria for the diagnosis of corticobasal degeneration

  Neurology · 2013 · 10.1212/wnl.0b013e31827f0fd1

• Phenomenology and classification of dystonia: A consensus update

  Movement Disorders · 2013 · 10.1002/mds.25475

• Impulse Control Disorders in Parkinson Disease

  Archives of Neurology · 2010 · 10.1001/archneurol.2010.65

• Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

  New England Journal of Medicine · 2009 · 10.1056/nejmoa0901281

• A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

  New England Journal of Medicine · 2009 · 10.1056/nejmoa0809335

• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  Movement Disorders · 2008 · https://doi.org/10.1002/mds.22340

• Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

  The Lancet Neurology · 2008 · 10.1016/s1474-4422(08)70117-0

• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan

  Movement Disorders · 2006 · 10.1002/mds.21198

• Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes

  Movement Disorders · 2006 · 10.1002/mds.20962

• Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease

  Annals of Neurology · 2006 · 10.1002/ana.20737

• Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

  Brain · 2005 · 10.1093/brain/awh571

• Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

  Annals of Neurology · 2003 · 10.1002/ana.10609

• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  Movement Disorders · 2003 · 10.1002/mds.10459

• A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa

  New England Journal of Medicine · 2000 · 10.1056/nejm200005183422004

• Consensus statement on the diagnosis of multiple system atrophy

  Journal of the Neurological Sciences · 1999 · 10.1016/s0022-510x(98)00304-9

• Parkinson's Disease

  New England Journal of Medicine · 1998 · 10.1056/nejm199810153391607

• Consensus statement on the diagnosis of multiple system atrophy

  Clinical Autonomic Research · 1998 · 10.1007/bf02309628

• Parkinson's Disease

  New England Journal of Medicine · 1998 · 10.1056/nejm199810083391506

• FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE

  Brain · 1986 · 10.1093/brain/109.5.845

Current projects

No projects listed.